Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 121.7% | 134.0% | 130.5% | 182.8% | 67.5% | 14.8% | 931.2% | 166.8% | 128.1% | 223.7% | 46.4% | 249.8% | 222.3% | 188.5% | 134.1% | 101.9% | 78.6% | 78.2% | 101.2% | 2,504.9% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 122.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Merck & Co., Inc. have been 314.3% over the past three years, and 261.4% over the past five years.
As of today, Merck & Co., Inc.'s FCF to Net Income is 122.1%, which is higher than industry median of 109.5%. It indicates that Merck & Co., Inc.'s FCF to Net Income is Good.